News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Civik Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 27,200 options to buy
@ $11.66, valued at
$317.2k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 66,831 shares
@ $0 |
|
| 11/19/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Bought 15,700 shares
@ $12.74, valued at
$200k
|
|
| 11/18/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 7,500 shares
@ $28.08, valued at
$210.6k
|
|
| 10/12/2021 |
4
| Civik Thomas (Director) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Granted 42,191 options to buy
@ $16, valued at
$675.1k
|
|
| 10/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2020 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 75,000 shares
@ $0
Granted 480,000 options to buy
@ $2.72, valued at
$1.3M
|
|
| 04/14/2020 |
3
| Civik Thomas (President and CEO) has filed a Form 3 on FIVE PRIME THERAPEUTICS, INC. |
| 08/02/2018 |
4
| Civik Thomas (Chief Commercial Officer) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Disposed of 33,421 shares
@ $137, valued at
$4.6M
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2017 |
3
| Civik Thomas (Chief Commercial Officer) has filed a Form 3 on Foundation Medicine, Inc. |
|
|